Acquisition of a High-Sensitivity Preclinical Quantitative microSPECT Imaging Systemview on SAM.gov

General Information Document Type: Presolicitation Synopsis Number: 75N98026Q00787 Posted Date: July 13, 2026 Original Response Date: July 23, 2026 Current Response Date: July 23, 2026 Set Aside: N/A NAICS Code: 334516 Contracting Office Address National Institutes of Health (NIH), Office of the Director (OD) Office of Logistics and Operations (OLAO) Office of Acquisition and Logistics Management (OALM) Hospital and Laboratory Support Division 6701 Rockledge Drive Bethesda, MD 20817 Description INTRODUCTION THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition (Including brand-name) to: LabLogic Systems, Inc. 3901 Centerview Drive Suite B Chantilly, VA 20151 NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE The intended procurement is classified under NAICS code 334516 with a Size Standard $1000. REGULATORY AUTHORITY The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2026-01, March 13, 2026. This acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold ($350,000). STATUTORY AUTHORITY This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and is not expected to exceed the simplified acquisition threshold. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. GENERAL INFORMATION Title: Acquisition of a High-Sensitivity Preclinical Quantitative microSPECT Imaging System Background Information: The Molecular Imaging Branch (MIB), Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), conducts translational research focused on molecular imaging, cancer biology, and radiopharmaceutical therapy. MIB maintains a broad portfolio of imaging and therapeutic programs involving diagnostic and therapeutic radionuclides including, but not limited to, Ac-225, Lu-177, I-131, Cu-67, and emerging therapeutic isotopes. Current research programs increasingly require rapid screening of novel radiopharmaceuticals, dynamic biodistribution assessment, longitudinal therapy monitoring, and imaging of emerging therapeutic radionuclides, including alpha-emitting isotopes. The new imaging system must support both quantitative tomographic imaging and rapid whole-body imaging workflows while maintaining a small laboratory footprint and simplified operation. Hardware aging, software obsolescence, and increasing maintenance requirements have significa…